Literature DB >> 17491357

Rapid regression of stage IVb invasive thymoma under palliative corticosteroid administration.

Taiki Fujiwara1, Teruaki Mizobuchi, Kiyoshi Shibuya, Kenzo Hiroshima, Takehiko Fujisawa, Naomichi Iwai.   

Abstract

A 53-year-old woman was referred to Matsudo City Hospital for palliative care of stage IVb invasive thymoma with multiple pulmonary metastases and dissemination. Moderate doses of corticosteroid were administered for palliative effects during the preterminal stage of the disease for 2 years. The thymoma progressed slowly but continuously. At age 55, she was admitted to our hospital for a whole-body eruption and high body temperature. We could not identify the pathogen or allergen. Based on the results of a skin biopsy, with the exception of corticosteroid we stopped administering all suspicious medications, including folk medicines. After 1 month of antipyretic therapy, whole-body eruption disappeared and we encountered rapid regression of the thymoma. Unfortunately she died of interstitial pneumonitis only 2 months after the regression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17491357     DOI: 10.1007/s11748-006-0099-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  7 in total

1.  Regression of invasive thymoma following corticosteroid therapy.

Authors:  A Termeer; F J Visser; M Mravunac
Journal:  Neth J Med       Date:  2001-04       Impact factor: 1.422

2.  Histopathologic changes of thymoma preoperatively treated with corticosteroids.

Authors:  H Tateyama; E Takahashi; Y Saito; I Fukai; Y Fujii; H Niwa; T Eimoto
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

3.  Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cells.

Authors:  Yasunobu Funakoshi; Hiroyuki Shiono; Masayoshi Inoue; Yoshihisa Kadota; Mitsunori Ohta; Hikaru Matsuda; Meinoshin Okumura; Tadaaki Eimoto
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-10       Impact factor: 4.553

4.  Dramatic response of postthymomectomy myasthenia gravis with multiple lung nodules to corticosteroids.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi; T Yasuda; H Funai
Journal:  Ann Thorac Surg       Date:  1997-08       Impact factor: 4.330

5.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

Review 6.  Thymoma.

Authors:  T I Morgenthaler; L R Brown; T V Colby; C M Harper; D T Coles
Journal:  Mayo Clin Proc       Date:  1993-11       Impact factor: 7.616

7.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

  7 in total
  2 in total

Review 1.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 2.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.